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Abstract
Background: The role of microRNA-200 (miR-200) family members in the migration and invasion of breast cancer is
controversial. This study investigated the mechanisms by which the miR-200 family members modulated the migratory
and invasive abilities of an aggressive triple-negative breast cancer (TNBC) cell line, MDA-MB-231.
Methods: The miR-200 family (miR-200b/200a/429 and miR-141/200c clusters) and green fluorescence protein (GFP)
were transduced into MDA-MB-231 cells using a lentiviral system. Stable cells highly expressing the miR-200 family and
GFP were isolated by puromycin selection and fluorescence-activated cell sorting. Gene expression was evaluated
using real-time polymerase chain reaction (PCR) and reverse transcriptase-PCR (RT-PCR). The migratory and invasive
abilities were assessed using trans-well and wound-healing assays. The secreted cytokines and growth factors in
cultured media were quantified using a Bio-Plex200 multiplex array system. Western blot assays and immunofluorescence
staining were conducted to investigate miR-200 family-regulated signaling pathways. The entire dataset obtained in
this study was statistically evaluated using a one-way ANOVA followed by a t-test.
Results: The stable overexpression of the miR-200b/200a/429 or miR-141/200c cluster suppressed cell growth and
significantly increased migration and invasion of MDA-MB-231 cells. miR-141/200c overexpression was more effective in
decreasing cell growth and promoting migration and invasion of MDA-MB-231 cells than was miR-200b/200a/429
overexpression. In addition, the overexpression of the miR-200b/200a/429 or miR-141/200c cluster led to an increase in
the phosphorylation of focal adhesion kinase (FAK) and protein kinase B (AKT). Chemical inhibitors of FAK and
phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K)/AKT suppressed the migration and invasion of MDA-MB-231 cells
that was enhanced by the overexpression of the miR-200b/200a/429 or miR-141/200c cluster. Compared to the miR-
200b/200a/429 cluster-transduced MDA-MB-231 cells, the miR-141/200c cluster-transduced MDA-MB-231 cells exhibited
a significant increase in vascular endothelial growth factor (VEGF)-A secretion and integrin-alphaV (integrin-αV)
expression. Treatment with an anti-VEGF-A-neutralizing antibody inhibited the increase in migration and invasion in
both the miR-200b/200a/429- and miR-141/200c-transduced MDA-MB-231 cells but significantly reduced the
phosphorylation of FAK and AKT in only the miR-141/200c cluster-transduced MDA-MB-231 cells.
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Conclusions: Taken together, our data demonstrate a mechanism in which the miR-141/200c cluster, through FAK-
and PI3K/AKT-mediated signaling by means of increased VEGF-A secretion, promotes the migratory and invasive
abilities of MDA-MB-231 cells.
Keywords: Triple-negative breast cancer (TNBC), microrna-200 (miR-200), Vascular endothelial growth factor
(VEGF), Migration, Invasion, Phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K), Protein kinase B (AKT), Focal
adhesion kinase (FAK)
Background
Aberrant expression of microRNAs (miRs), which are
small non-coding RNA molecules consisting of approxi-
mately 22 nucleotides, has been identified in human
cancer, where the miRNA signature is associated with
specific clinical and biological features [1]. The micro-
RNAs related to cancers may act as tumor suppressors
or oncogenes, depending on the cancer type [2, 3]. The
miR-200 family member genes are clustered at two loca-
tions in the genome: the miR-200b/200a/429 cluster and
the miR-141/200c cluster [4]. The miR-200 family mem-
bers repress the epithelial-to-mesenchymal transition
(EMT), cancer cell migration, tumor growth, and metas-
tasis by directly targeting specific genes, such as ZEB1,
Suz12, moesin, and AP-2γ [4, 5]. In contrast, the miR-
200 family members have been shown to enhance the
migration ability of breast cancer cells and to promote the
metastatic colonization of breast cancer cells through
up-regulating the expression of E-cadherin and down-
regulating that of ZEB2 and Sec23a [6, 7]. In a recent
study, high expression of the miR-200 family was associ-
ated with a high probability of relapse, poor survival, and
distant metastasis in breast cancer patients [8]. The loss of
miR-200c expression has also been related to the induc-
tion of an aggressive, invasive, and chemoresistant pheno-
type of non–small cell lung cancer [9]. Conflicting results
have been obtained in studies of the role of each miR-200
family member in repressing or enhancing cancer cell
migration and invasion as well as the tumor growth
and metastasis of diverse cancers, including breast
cancer [10, 11].
Triple-negative breast cancer (TNBC) lacking estrogen
receptor (ER), progesterone receptor (PR), and human
epidermal growth factor receptor 2 (HER2) expression,
is a highly invasive and metastatic form of breast cancer
with a generally poorer prognosis than that of other
breast cancer subtypes [12]. It is important to develop
new treatment strategies based on a better understand-
ing of the underlying mechanisms regulating the aggres-
sive behavior of TNBCs. TNBCs express the miR-200
family members at a significantly lower level than do
other subtypes of breast cancer, such as ER-positive or
HER2-positive breast cancer [13]. Only a small number
of the miR-200 target genes that are involved in breast
cancer cell migration and metastasis have been identified
[4–6], and few studies of the role of the miR-200b/200a/
429 or miR-141/200c cluster in human TNBC have been
conducted. The biological relevance of the function of
the miR-200b/200a/429 or miR-141/200c cluster in hu-
man TNBC remains to be discovered.
Synthetic miR-200b directly downregulates vascular
endothelial growth factor (VEGF) in endothelial cells
and prevents the diabetes-induced increase in VEGF,
thus inhibiting angiogenesis in diabetic retinopathy [14].
Chemokine CCL5 (formerly RANTES) of the CC-
chemokine family, which plays a critical role in local
invasion and distant metastasis in chondrosarcoma, pro-
motes VEGF expression and angiogenesis by downregu-
lating miR-200b [15]. The miR-200c radiosensitized the
lung cancer cell line, A549 by targeting the VEGF-
VEGFR2 pathway [16]. From these reports, we specu-
lated that the overexpression of the miR-200 family can
regulate the expression and secretion of cytokines and
growth factors involving in cell growth and migratory
and invasive abilities of TNBC cells.
In the present study, we used MDA-MB-231 cells, a
typical human TNBC cell line, which were stably trans-
duced with lentivirus carrying miR-200 family. We found
that the overexpression of the miR-141/200c cluster pro-
moted stronger migration and invasion as well as higher
VEGF-A secretion in MDA-MB-231 cells. Therefore, we
investigated, in detail, the mechanisms by which two
miR-200 family members, the miR-200b/200a/429 clus-
ter and the miR-141/200c cluster, regulated MDA-MB-
231 cell migration and invasion. We demonstrate that
the overexpression of the miR-141/200c cluster in
MDA-MB-231 cells increased VEGF-A secretion, which
enhanced the migratory ability of the cells through the
activation of focal adhesion kinase (FAK) and the
phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K)/
protein kinase B (AKT) signaling pathway.
Methods
Cell culture
The human breast cancer cell lines MCF-7 (ER-positive
subtype), MDA-MB-231 and HCC-38 (TN subtype)
were obtained from the Korean Cell Line Bank (Seoul,
Korea). Hs578T cells (TN subtype) were obtained from
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ATCC (Manassas, VA, USA). MCF-7 cells were grown in
Dulbecco’s Modified Eagle’s Medium (DMEM) (WelGENE,
Daegu, Korea) containing 10 % fetal bovine serum (FBS)
and supplemented with a 1 % antibiotic solution contain-
ing penicillin and streptomycin (Gibco, Auckland, NZ).
The MDA-MB-231, HCC-38, and Hs578T cells were
grown in Roswell Park Memorial Institute (RPMI) 1640
medium (WelGENE) containing 10 % FBS and supple-
mented with a 1 % antibiotic solution containing penicillin
and streptomycin (Gibco). The MCF-7, MDA-MB-231,
HCC-38, and Hs578Tcells used in this study were authen-
ticated and validated by DNA fingerprinting (AmplFLSTR
identifiler PCR Amplification kit), which was conducted
by the Korean Cell Line Bank.
Lentiviral transduction
Viral vectors containing either the miR-200b/200a/429
cluster (GenBank ID: 406984 406983) or the miR-141/
200c cluster (GenBank ID: 406985 406933) constructs
and the green fluorescent protein (GFP) construct were
kindly supplied by Dr. Gregory J. Goodall of the Univer-
sity of Adelaide (Adelaide, Australia). A viral vector
(pLenti M1.41) containing GFP was used as a control
vector. Lentiviral transduction was conducted according
to the manufacturer’s instructions. Briefly, cells were
seeded at a density of approximately 10–25 % confluency
(1 × 105 cells) in 6-well plates and were maintained at
37 °C with 5 % CO2. Following an overnight culture, the
culture medium was removed. Aliquots of the lentiviral
stocks containing the miR-200b/200a/429 cluster or the
miR-141/200c cluster construct as well as the control
virus were gently mixed with 8 μg/ml polybrene and
added to each well. After 6 h of transduction, the
medium was replaced with fresh complete medium.
Transduced cells with a cell density of greater than 90 %
confluency were selected using medium containing
3 μg/ml puromycin for 2 weeks. Then, the GFP-positive
cells were sorted from the selected cells using a FACS-
Calibur flow cytometer (BD Biosciences, Franklin Lakes,
NJ, USA). Cancer cells stably expressing the miR-
200b/200a/429 cluster or the miR-141/200c cluster
and GFP, denoted as miR-200ab cells and miR-200c
cells, respectively, and cancer cells containing the
pLenti M1.41 vector, denoted as control cells, were
generated and expanded for use in all subsequent
studies.
Quantitative real-time PCR
TaqMan MicroRNA Assays (Applied Biosystems, South
San Francisco, CA, USA) were used to quantify the
levels of mature miRNAs, following the manufac-
turer’s instructions. The miRNAs were isolated from
cells using the mirVana miRNA isolation kit (Applied
Biosystems), and the specific primers for detecting
miR-200a, miR-200b, and, miR-200c were purchased
from Applied Biosystems. Reverse transcription was
performed using the TaqMan microRNA reverse tran-
scription kit (Applied Biosystems) according to the
manufacturer’s instructions. The traditional TaqMan
Assay control, 18 s rRNA, was used as the endogen-
ous control. Each TaqMan Assay was conducted in
triplicate.
Reverse transcriptase polymerase chain reaction (RT-PCR)
The total RNA was isolated using TRIzol Reagent (Invitro-
gen, Carlsbad, CA, USA) and reverse-transcribed using
random hexamers and Superscript III reverse transcript-
ase. The cDNAs were synthesized using M-MLV reverse
transcriptase (New England Biolabs, Ipswich, MA, USA)
and random primers. The mRNA levels in the miR-200
family-transduced cells and non-transduced cells, referred
to as the control, were evaluated using the conventional
RT-PCR method with the following primer sets: E-
cadherin (421 bp), F, ATTCTGATTCTGCTGCTCTTG
and R, AGTAGTCATAGTCCTGGTCTT; Vimentin
(247 bp), F, CCCTCACCTGTGAAGTGGAT and R, TCC
AGCAGCTTCCTGTAGGT; ZEB1 (150 bp), F, TTC
AAACCCATAGTGGTTGCT and R, TGGGAGATACC
AAACCAACTG; ZEB2 (127 bp), F, CAAGAGGCGC
AAACAAGC and R, GGTTGGCAATACCGTCATCC;
Snail (557 bp), F, CAGACCCACTCAGATGTCAA and R,
CATAGTTAGTCACACCTCGT; Fibronectin (171 bp), F,
CAGAATCCAAGCGGAGAGAG and R, CATCCTCAG
GGCTCGAGTAG; and β-actin (335 bp), F, TTCCTG
GGCATGGAGTCCTGTGG, and R, CGCCTAGAAGC
ATTTGCGGTGG. Each target gene was amplified using
a Thermocycler (BioRad, Hercules, CA, USA). The PCR
products were subjected to electrophoresis through 1.5 %
agarose gels, and the levels of gene expression were nor-
malized to that of β-actin.
Cell viability and proliferation assay
In vitro cell viability and proliferation were assessed using
the 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium
bromide (MTT) assay. Briefly, 5 × 103 cells were allowed
to adhere in a high-humidity environment in 5 % CO2 at
37 °C in 96-well culture plates. At 1 d, 3 d, and 5 d after
cell seeding, the MTT solution (a final concentration of
1 mg/ml) was added, and the cells were incubated for 1 h.
At the end of the incubation period, the MTT solution
was carefully removed, and 150 μl of dimethyl sulfox-
ide was added to each well. The plates were main-
tained on a rocker shaker for 10 min at 25 °C, and
then the amount of MTT formazan crystals formed by
the viable cells was determined using a spectropho-
tometer based on the absorbance at 540 nm (GE
Healthcare, Piscataway, NJ, USA). Flow cytometry
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analysis using 7-AAD was performed to confirm cell
viability.
Migration and invasion assay
To assess the cell migratory ability, 2–5 × 104 cells were
suspended in 100 μl of medium with or without 10 %
FBS and deposited in the upper chambers of a trans-well
plate with 8.0-μm pores (BD Biosciences) with a non-
coated membrane. For the invasion assays, 5 × 104 cells
were plated in 2 % Matrigel™ (BD Biosciences) basement
membrane matrix-coated upper chambers in a trans-
well plate with 8.0-μm pores. The lower chambers were
filled with 600 μl of medium supplemented with 10 %
FBS, and the cells were incubated for 48 h at 37 °C in
the presence or absence of an FAK inhibitor (5 μM
PF573228, Sigma, St. Louis, MO, USA), a PI3K/AKT in-
hibitor (20 μM LY294002, Cell Signaling Technology,
Danvers, MA, USA), 5 μg/ml VEGF-neutralizing anti-
body (Santa Cruz Biotechnology, Dallas, TX, USA) or
10 ng/ml VEGF-A protein (Sigma). Each inhibitor,
VEGF-neutralizing antibody, or VEGF-A were added in
both the upper and lower chambers. No chemoattrac-
tants were used in the lower chamber for either the mi-
gration or invasion assays. The cells that migrated from
the upper chamber were stained using a crystal violet so-
lution (0.5 % crystal violet in 20 % methanol) for 5 min.
Unbound crystal violet was removed by rinsing using
distilled water. The cells were subsequently air-dried,
and the crystal violet was eluted from the cells using a
solution of 1 % sodium dodecyl sulfate (SDS). The ab-
sorbance of crystal violet at 550 nm was measured using
a spectrophotometer (GE Healthcare).
Wound-healing assay
Cells were seeded at 5 × 104 cells per well in six-well
plates and cultured under permissive conditions until
reaching 90 % confluence. After 24 h, each confluent cell
monolayer was lightly and quickly scratched using a
sterile plastic tip to produce a straight line. The debris
was removed, and the edge of the scratch was smoothed
by washing with PBS. The cells were cultured for 6 h in
complete medium, after which, the lateral migratory ac-
tivity was evaluated based on the area occupied by the
cells that had entered the scratch line at 0 h. Images
were acquired using a microscope (Leica, Wetzlar,
Germany) equipped with a CCD camera (Leica). The mi-
gration rates were calculated according to the equation
percentage wound healing = {(wound length at 0 h) -
(wound length at 6 h)} / (wound length at 0 h) × 100.
The mean results of three straight distances (upper edge,
middle, and lower edge) in scratch area were evaluated
as wound lengths. Length quantification was performed
using ImageJ software (NIH, Bethesda, MD, USA).
Measurement of cytokines and growth factors
Samples of 1–2 × 105 cells were seeded in 6-well plates.
After a two-day culture period, when cells were at 90 %
confluency, the conditioned medium was harvested.
The levels of secreted cytokines and growth factor
(IL-2, IL-4, IL-5, IL-10, IL-12, IL-13, GM-CSF, IFN–γ,
and VEGF-A) were quantified using the Bio-Plex200
multiplex array system according to the recommended
protocol (Bio-Rad). All samples and standardized so-
lutions were analyzed in triplicate.
Western blotting
The cells were lysed in RIPA buffer (Sigma). The proteins
were separated using SDS-polyacrylamide gel electrophor-
esis and were transferred to nitrocellulose membranes.
The membranes were blocked using 5 % skim milk in
Tris-buffered saline containing Tween and incubated with
primary antibodies directed against ERK, phospho-ERK,
AKT (anti-rabbit polyclonal antibody, Cell Signaling
Technology), phospho-AKT (anti-mouse polyclonal anti-
body, Cell Signaling Technology), FAK (anti-rabbit poly-
clonal antibody, Invitrogen), phospho-FAK (anti-rabbit
polyclonal antibody, Invitrogen), integrin-αV (anti-rabbit
polyclonal antibody, Santa Cruz Biotechnology) or β-actin
(anti-mouse polyclonal antibody, Sigma) overnight at 4 °C.
The membranes were then incubated with horseradish
peroxidase-conjugated secondary antibodies (Santa Cruz
Biotechnology). The blotted membranes were visualized
using enhanced chemiluminescence reagents (GE Health-
care). Western blot quantification was performed using
ImageJ software.
Immunofluorescence staining
The cells were seeded on sterile cover slips in 24-well
plates. Then, the cells were fixed using a 4 % para-
formaldehyde solution (Affymetrix, Cleveland, OH,
USA). Primary antibodies directed against integrin-αV
(Santa Cruz Biotechnology) and phospho-FAK (Invi-
trogen) were applied overnight at 4 °C. The bound
integrin-αV and phospho-FAK antibodies were visual-
ized using secondary antibodies conjugated to Alexa
594, and the nuclei were counterstained using 4',6-dia-
midino-2-phenylindole (DAPI). All multicolor fluorescence
images were obtained using a confocal laser-scanning
microscopy (LSM5 Meta) (Carl Zeiss, Oberkochen,
Germany).
Statistical analyses
For the entire dataset obtained in this study, the mean
values ± standard deviations were calculated from the re-
sults of at least three independent experiments and were
statistically evaluated using a one-way ANOVA followed
by the t-test. For all tests, p-values of less than 0.05 were
considered significant.
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Results
Overexpression of the miR-200b/200a/429 cluster or the
miR-141/200c cluster enhanced the migratory and
invasive abilities of MDA-MB-231 cells
We first investigated alterations in the characteristics of
two different breast cancer cell lines, MCF-7 and MDA-
MB-231 cells, caused by the stable transduction of con-
structs encoding miR-200 family members and GFP
using lentiviruses. The GFP-positive cells comprised
more than 95 % of the miR-200b/200a/429 cluster- or
miR-141/200c cluster-transduced MCF-7 and MDA-
MB-231 cells (Additional file 1: Figure S1 and Additional
file 2: Figure S2). Strong GFP expression in the miR-200b/
200a/429 cluster- or miR-141/200c cluster-transduced
MCF-7 and MDA-MB-231 cells was evaluated using mi-
croscopy (Fig. 1a and Additional file 1: Figure S1A). RT-
PCR was used to evaluate expression levels of EMT
markers, and the results showed that the overexpression
of the miR-200b/200a/429 cluster or the miR-141/200c
cluster resulted in the induction of E-cadherin expression
and a decrease in ZEB-1 expression in MDA-MB-231 cells
(Additional file 1: Figure S1B). Overexpression of the miR-
200b/200a/429 or miR-141/200c cluster led to increased
expression of Snail in MCF-7 and MDA-MB-231 cells.
To investigate the stable overexpression of miR-200a,
miR-200b, miR-200c in miR-200b/200a/429 cluster- or
miR-141/200c cluster-transduced MDA-MB-231 cells,
real-time RT-PCR was conducted to quantify the levels
of the mature microRNAs. As expected, the miR-200b/
200a/429 cluster- and miR-141/200c cluster-transduced
MDA-MB-231 cells showed increased mature miR-200a,
miR-200b, and miR-200c levels at 5-100-fold higher
levels than did the control MDA-MB-231 cells, which
exhibited undetectable levels of all members of the miR-
200 family (Fig. 1b).
To investigate whether overexpression of the miR-
200b/200a/429 or miR-141/200c cluster affected cell
growth, an MTT assay was performed. Figure 1c shows
Fig. 1 Proliferation, migration, and invasion of miR-200b/200a/429- or miR-141/200c-transduced MDA-MB-231 cells. a Fluorescence images of
green fluorescent protein in MCF-7 and MDA-MB-231 cells that were transduced using lentivirus encoding both GFP and miR-200 family members.
Strong GFP expression was detected in the miR-200 family-transduced cells. Scale bar; 50 μm. b Quantitative real-time RT-PCR of microRNAs (miR-200a,
miR-200b, and miR-200c). The miR-200ab cells transduced with the miR-200b/200a/429 cluster construct exhibited high expression levels of miR-200a
(~6-fold) and miR-200b (~40-fold) relative to those of the control cells. The miR-200c cells transduced with the miR-200c/141 cluster
construct exhibited remarkably high expression levels of miR-200c (~93-fold) and miR-200b (~8-fold) relative to those of the control cells. c MTT assay for
analysis of cell proliferation. The growth rate was significantly lower in the miR-200c cells (~4-fold) than in the control cells (~6-fold) at the 5th day. d
Trans-well migration assay for the analysis of cell migration. e Trans-well invasion assay for the analysis of the invasive capacity. The migratory and invasive
abilities of the miR-200ab and miR-200c cells (~2-fold) were significantly increased compared with those of the control cells. The enhanced migratory
and invasive abilities were higher in miR-200c cells than in miR-200ab cells. All experiments were performed at least in triplicate, and the values are the
mean values ± standard deviation. *p < 0.05, **p< 0.001
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that the growth rate of the miR-200b/200a/429 cluster-
or miR-141/200c cluster-transduced MDA-MB-231 cells
was similar to that of the control cells on the 3rd day
but was significantly decreased on the 5th day after cell
seeding compared with that of the control cells (control
vs. miR-200ab, p = 0.02 and control vs. miR-200c, p =
0.0002) (Fig. 1c). The overexpression of the miR-141/
200c cluster was found to more strongly suppress the
growth of MDA-MB-231 cells.
We assessed migratory and invasive abilities using a
trans-well migration assay and a wound-healing assay.
The results of crystal violet staining showed that the mi-
gratory ability of MCF-7 cells was suppressed by transduc-
tion of the miR-200 family, but there was no significant
difference between that of the miR-200b/200a/429 cluster-
or miR-141/200c cluster-transduced MCF-7 cells and
control cells (Additional file 1: Figure S1C, E). The
wound-healing assay, which demonstrated the lateral mi-
gratory ability of MCF-7 cells, yielded results similar to
those of the trans-well migration assay (Additional file 1:
Figure S1D, F).
With regard to the trans-well migration and invasion
assays of the miR-200b/200a/429 cluster- or miR-141/
200c cluster-transduced MDA-MB-231 cells, after 48 h
of incubation without an FBS gradient, cell migration
significantly increased up to 1.94 ± 0.22-fold and 2.49 ±
0.08-fold in miR-200b/200a/429 cluster- or miR-141/
200c cluster-transduced MDA-MB-231 cells, respect-
ively, compared with control cells (Fig. 1d control vs.
miR-200ab, p = 0.04 and control vs. miR-200c, p = 0.002).
To further investigate the migratory ability of miR-141/
200c cluster-transduced MDA-MB-231 cells, the trans-
well migration assay under the condition of a 10 % FBS
gradient in the upper (0 % FBS) and the lower chamber
(10 % FBS) was conducted for 24 h. A significant increase
was observed in the migratory ability of the miR-141/
200c-transduced MDA-MB-231 cells (1.53 ± 0.30-fold)
relative to MDA-MB-231 cells (Additional file 3: Figure S3,
p = 0.0009). As expected, the results of an invasion assay
using Matrigel™ matrix-coated trans-well membranes
showed a significant increase in the invasive ability of the
miR-200b/200a/429 cluster-transduced cells (1.61 ± 0.31-
fold) and miR-141/200c cluster-transduced cells (1.98 ±
0.40-fold) after 48 h of incubation compared with that of
control cells (Fig. 1e, control vs. miR-200ab, p = 0.0005
and control vs. miR-200c, p = 0.0002). The elevated migra-
tion and invasion rates were higher in miR-141/200c
cluster-transduced MDA-MB-231 cells than miR-200b/
200a/429 cluster-transduced MDA-MB-231 cells. After
6 h of incubation, the transduction of miR-200b/200a/429
cluster or miR-141/200c cluster did not affect the lateral
migratory ability of MCF-7 cells, but increased the lateral
migration up to 2.78 ± 0.11-fold and 1.69 ± 0.11-fold in
miR-200b/200a/429 cluster- or miR-141/200c cluster-
transduced MDA-MB-231 cells, respectively (p = 0.02,
Additional file 1: Figure S1F). In other TNBC cell lines,
HCC-38 and Hs578T cells, we observed a significant in-
crease in trans-well migration ability in both the miR-141/
200c cluster-transduced HCC-38 cells (1.64 ± 0.11-fold,
p < 0.001) and miR-141/200c cluster-transduced Hs578T
cells (1.76 ± 0.44-fold, p = 0.0003) compared with the con-
trol cells (Additional file 4: Figure S4A, D). The mature
miR-200c levels in miR-141/200c cluster-transduced
HCC-38 and Hs578T cells were 252- and 205-fold higher
than that in the control HCC-38 and Hs578T cells, which
exhibited undetectable levels of miR-200c (p < 0.001,
Additional file 5: Figure S5G, H).
We found that the overexpression of the miR-200b/
200a/429 cluster or the miR-141/200c cluster resulted in
the highest migratory capacity in MDA-MB-231 cells
compared with the other TNBC cells, HCC-38 and
Hs578T cells. Therefore, we focused on the regulatory
mechanisms by which the miR-200b/200a/429 cluster or
the miR-141/200c cluster promoted the migratory and
invasive capacities of the MDA-MB-231 cell line, as a
representative TNBC cell line.
Overexpression of the miR-200b/200a/429 cluster or the
miR-141/200c cluster enhanced the phosphorylation of FAK
and AKT and the expression of integrin in MDA-MB-231
cells
We investigated whether the overexpression of miR-200
family members modulated the focal adhesion kinase
(FAK), PI3K/AKT, and MEK/ERK signaling pathways,
which are involved in cell proliferation and migration.
Representative western blotting results showed that the
levels of FAK and AKT phosphorylation were greatly in-
creased, but the level of ERK phosphorylation was not
significantly changed in the miR-200b/200a/429 cluster-
or miR-141/200c cluster-transduced MDA-MB-231 cells
(Fig. 2a, left). The level of phosphorylated FAK was sig-
nificantly increased up to 1.52 ± 0.26-fold and 3.12 ±
1.56-fold in the miR-200b/200a/429 cluster-transduced
cells and miR-141/200c cluster-transduced cells, respect-
ively (Fig. 2a, right, control vs. miR-200ab, p = 0.01 and
control vs. miR-200c, p = 0.09). The level of phosphory-
lated AKT was also increased 2.21 ± 1.06-fold and 9.32 ±
11.07-fold in the miR-200b/200a/429 cluster-transduced
cells and miR-141/200c cluster-transduced cells, respect-
ively (Fig. 2a, right, control vs. miR-200ab, p = 0.19 and
control vs. miR-200c, p = 0.32). We also observed that the
miR-141/200c cluster significantly increased the phos-
phorylation levels of FAK (1.98 ± 0.37-fold, p = 0.04)
and AKT (5.61 ± 1.73-fold, p = 0.04) in HCC-38 cells
(Additional file 6: Figure S6C, D). Representative west-
ern blotting results showed that the expression levels of
integrin-αV, which is associated with the FAK signaling
pathway, were increased in both the miR-200b/200a/429
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cluster- and miR-141/200c cluster-transduced cells (Fig. 2b,
left). Integrin-αV expression was increased 1.57 ± 0.10-fold
and 1.70 ± 0.24-fold in the miR-200b/200a/429 cluster-
transduced cells and miR-141/200c cluster-transduced
cells, respectively (Fig. 2b, right, control vs. miR-200ab,
p = 0.01 and control vs. miR-200c, p = 0.04). Integrin-
αV expression was also increased (13.61 ± 0.72-fold,
p = 0.008) in miR-141/200c cluster-transduced HCC-
38 cells (Additional file 6: Figure S6C, D). To investi-
gate the cellular localization of phosphorylated FAK
and integrin-αV, immunofluorescent staining was
assessed. Phosphorylated FAK was largely localized at
the focal adhesions of the plasma membranes of the
miR-200b/200a/429 cluster- and miR-141/200c cluster-
transduced cells (Fig. 2c). Integrin-αV accumulated and
clustered at the periphery of the plasma membranes of the
miR-200b/200a/429- and miR-141/200c-transduced cells
compared with that in control cells (Fig. 2c). The levels
of FAK phosphorylation and integrin-αV expression
were higher in the miR-141/200c cluster-transduced
HCC-38 cells than in the control cells (Additional file 6:
Figure S6E).
To determine the signaling pathway involved in en-
hanced migratory and invasive ability of miR-200b/200a/
429 cluster- or miR-141/200c cluster-transduced MDA-
MB-231 cells, trans-well migration assays were performed
Fig. 2 Signaling pathway associated with enhanced migration in miR-200b/200a/429 or miR-141/200c-transduced MDA-MB-231 cells. a, b Western
blotting analysis of the levels of phosphorylated FAK, AKT, ERK, and integrin-αV expression. The levels of FAK and AKT phosphorylation were
significantly higher in the miR-200 family-transduced cells than in the control cells, but the level of ERK phosphorylation was similar between the miR-
200 family-transduced cells and control cells. The miR-200 family-transduction also increased integrin-αV expression. Densitometric quantifications of
FAK, AKT, and ERK phosphorylation in the miR-200 family-transduced cells relative to control cells. β − actin was used as an internal reference.
c Immunofluorescence analysis of phosphorylated FAK and integrin-αV. Phosphorylated FAK and integrin-αV were overexpressed and were highly
localized at membrane surfaces in the miR-200 family-transduced cells. d Trans-well migration assay of FAK (PF573228) and PI3K/AKT (LY294002)-inhibitor-
treated cells. Treatment with inhibitors of the FAK and PI3K/AKT signaling pathways significantly suppressed the cell migration enhanced by
the transduction of miR-200 family. All experiments were performed at least in triplicate, and the values are the mean values ± standard deviation.
*p < 0.05 **p < 0.001, Scale bar, 10 μm
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in the presence of PF573228 or LY294002, which are
chemical inhibitors of FAK and PI3K/AKT, respectively.
The chemical inhibitors were added to both the upper
and lower chambers, which would allow their effects to
last throughout the entire experimental period. The en-
hanced migratory activity was completely inhibited in
miR-200b/200a/429 cluster- and miR-141/200c cluster-
transduced MDA-MB-231 cells treated with the FAK or
PI3K/AKT inhibitor, reaching the basal migratory level of
MDA-MB-231 cells (Fig. 2d). These observations demon-
strated that the elevated migratory ability of MDA-MB-
231 cells by stable overexpression of miR-200b/200a/429
cluster or miR-141/200c cluster was driven by the ac-
tivation of the FAK and PI3K/AKT-mediated signaling
pathways.
Overexpression of the miR-200b/200a/429 cluster or the
miR-141/200c cluster increased the level of VEGF-A secretion
in MDA-MB-231 cells
The secreted cytokines or growth factors that might be
involved in regulating the migration of the miR-200b/
200a/429 cluster- or miR-141/200c cluster-transduced
cells were analyzed. The levels of IL-2, GM-CSF, and
IFN-γ secreted into the medium by the miR-200b/200a/
429 cluster- and miR-141/200c cluster-transduced MDA-
MB-231 cells after 48 h of culture were lower than those
of the control MDA-MB-231 cells. However, the secreted
VEGF-A levels were significantly higher in the condi-
tioned medium of the miR-200b/200a/429 cluster-
transduced cells (1.64 ± 0.03-fold) and miR-141/200c
cluster-transduced cells (2.66 ± 0.09-fold) than in that of
the control MDA-MB-231 cells (Fig. 3a, control vs. miR-
200ab, p = 0.007 and control vs. miR-200c, p = 0.0007). In-
creased secretion of VEGF-A was higher in miR-141/200c
cluster-transduced cells than miR-200b/200a/429 cluster-
transduced cells (miR-200ab vs. miR-200c, p = 0.0001).
The secreted levels of cytokines and growth factors were
also evaluated in the miR-141/200c cluster-transduced
HCC-38 and Hs578T cells. VEGF-A secretions were sig-
nificantly increased in miR-141/200c cluster-transduced
HCC-38 (1.75 ± 0.03-fold, p = 0.00001) and miR-141/200c
cluster-transduced Hs578T cells (1.17 ± 0.16-fold, p = 0.004)
relative to control cells (Additional file 4: Figure S4B, E).
The effect of miR-141/200c overexpression on increased
cell migration and VEGF-A secretion was greater in
MDA-MB-231 cells relative to HCC-38 and Hs578T cells.
There were no definite differences in VEGF-A secretion
levels between the miR-141/200c cluster–transduced
Hs578T and the control Hs578T cells. These results were
explained by the phenotypic and functional heterogeneity
among cancer cells in TNBC cells. The VEGF-A expres-
sion levels were also examined in the miR-200b/200a/429
cluster- or miR-141/200c cluster-transduced MDA-MB-
231 cells, but the transduction of miR-200b/200a/429
cluster (1.18 ± 0.31-fold) or miR-141/200c cluster (0.90 ±
0.34-fold) did not affect VEGF-A expression (Fig. 3b, right,
control vs. miR-200ab, p = 0.38 and control vs. miR-200c,
p = 0.45). The miR-141/200c cluster–transduced HCC-38
cells (0.92 ± 0.09-fold) also expressed VEGF-A levels that
were similar to the control HCC-38 cells (Additional file 6:
Figure S6A, B, p = 0.46).
Blocking VEGF-A activity inhibited the enhanced migration
and invasion of miR-200b/200a/429 cluster or miR-141/
200c cluster-transduced MDA-MB-231 cells
To examine whether secreted VEGF-A regulates the mi-
gratory and invasive abilities of the miR-200b/200a/429
cluster- or miR-141/200c cluster-transduced MDA-MB-
231 cells, trans-well migration and invasion assays were
performed after treatment with anti-VEGF-A-neutraliz-
ing antibodies. The anti-VEGF-A-neutralizing antibodies
were added to both the upper and lower chamber, which
would allow their effects to last throughout the entire
experimental period. Figure 3c, d d showed that the
anti-VEGF-A-neutralizing antibodies completely inhib-
ited the increased migratory (control vs. miR-200ab, p =
0.0001 and control vs. miR-200c, p = 0.002) and invasive
(control vs. miR-200ab, p = 0.02 and control vs. miR-
200c, p = 0.001) abilities of the miR-200b/200a/429 clus-
ter- and miR-141/200c cluster-transduced cells. These
data clearly indicated that secreted VEGF-A was in-
volved in promoting the migration and invasion of both
miR-200b/200a/429 cluster- and miR141/200c cluster-
transduced cells. The administration of anti-VEGF-A-
antibodies for neutralizing VEGF-A in cultured medium
suppressed the migration increased by miR-141/200c
overexpression in both the miR-141/200c cluster-
transduced HCC-38 and miR-141/200c cluster-transduced
Hs578T cells (Additional file 4: Figure S4C, F). The anti-
VEGF-A-neutralizing antibodies also completely inhibited
the increased migratory ability (control vs. miR-200c, p <
0.001) of the miR-141/200c cluster-transduced HCC-38
cells (Additional file 4: Figure S4C, untreated vs. VEGF-A
Ab, p < 0.001). These results supported that VEGF-A se-
cretion was associated with enhancing migration ability in
TNBC cells. The anti-VEGF-A-neutralizing antibodies
partly blocked the enhanced migratory ability (control vs.
miR-200c, untreated, 1.76 ± 0.44-fold, p = 0.0003) of both
the control (0.80 ± 0.07-fold, p = 0.003) and the miR-141/
200c cluster-transduced Hs578T cells (1.37 ± 0.21-fold,
p = 0.003), but the miR-141/200c cluster-transduced
Hs578T cells still showed increased migratory ability
compared with that of the control cells (control vs. miR-
200c, VEGF-A Ab treated, p < 0.001, Additional file 4:
Figure S4F). These results imply that other factors besides
VEGF-A may also be involved in promoting migration in
miR-141/200c cluster-transduced Hs578T cells.
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The miR-141/200c cluster activated the FAK and PI3K/AKT
signaling pathway by secreted VEGF-A, resulting in the
promotion of the migratory and invasive abilities of
MDA-MB-231 cells
To ascertain the VEGF-A-mediated intracellular signal-
ing pathway responsible for the increased migratory and
invasive abilities of miR-200b/200a/429 cluster- or miR141/
200c cluster-transduced MDA-MB-231 cells, the levels of
FAK and AKT phosphorylation were evaluated in cells
treated with 5 μg/ml anti-VEGF-A-neutralizing antibodies.
Treatment with anti-VEGF-A-neutralizing antibodies for
both 30 min and 48 h remarkably decreased the level of
Fig. 3 Migration and invasion in miR-200b/200a/429 or miR-141/200c-transduced MDA-MB-231 cells treated with an anti-VEGF-A-neutralizing
antibody. a Measurement of the secreted levels of cytokines and growth factors (IL-2, IL-4, IL-5, IL-10, IL-12, IL-13, GM-CSF, IFN-γ, TNF-α, and VEGF-
A). Transduction of the miR-200 family into MDA-MB-231 cells promoted significantly higher VEGF-A secretion than that of control cells. b Western
blotting analysis of the levels of VEGF-A. c Trans-well migration and d invasion assay of anti-VEGF-A-neutralizing antibody-treated cells. The
enhanced migration and invasion of the miR-200 family-transduced cells were significantly suppressed by treatment with anti-VEGF-A-neutralizing
antibodies. e, f Representative image of western blotting of phosphorylated AKT, FAK, and ERK and total AKT, FAK and ERK in cells treated with
anti-VEGF-A-neutralizing antibodies for 30 min and 48 h. The elevated phosphorylation levels of FAK and AKT in only miR-141/200c cluster-
transduced cells but not miR-200b/200a/429-transduced cells were decreased by the anti-VEGF-A-neutralizing antibody, whereas the phosphorylation
level of ERK was increased in miR-141/200c -transduced cells and control cells treated with anti-VEGF-A-neutralizing antibodies. All experiments were
performed at least in triplicate, and the values are the mean values ± standard deviation. N.D: not detectable. *p < 0.05, **p < 0.001
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FAK and AKT phosphorylation in the miR-141/200c
cluster-transduced MDA-MB-231 cells and the control
cells but did not affect the level of phosphorylated FAK
and AKT in the miR-200b/200a/429 cluster-transduced
MDA-MB-231 cells (Fig. 3e, f ). In contrast, the level of
ERK phosphorylation was increased by anti-VEGF-A-neu-
tralizing antibodies in miR-141/200c-transduced cells and
control cells. These data implied that FAK and AKT acted
as a direct link between elevated VEGF-A secretion and
the consequential signal transduction related to enhanced
migration of miR-141/200c cluster-transduced MDA-MB-
231 cells, but the increased secretion of VEGF-A in miR-
200b/200a/429 cluster-transduced MDA-MB-231 cells
was not directly followed by activation of the FAK and
AKT-mediated signaling pathway, which was possibly in-
duced by the other signaling pathways.
Exogenous VEGF-A stimulated migration of MDA-MB-231
cells by activating the FAK and PI3K/AKT pathway
To confirm the role of VEGF-A as a migration-
activating mediator in miR-200b/200a/429 cluster- or
miR-141/200c cluster-transduced MDA-MB-231 cells, a
trans-well migration assay was assessed in MCF-7 and
MDA-MB-231 cells treated with exogenous VEGF-A
protein. The representative crystal violet staining of ex-
ogenous VEGF-A (10 ng/ml)-treated MCF-7 and MDA-
MB-231 cells that had migrated through the trans-well
membranes after 48 h is shown in Fig. 4a. A quantitative
analysis of a crystal violet assay showed that exogenous
VEGF-A significantly increased MDA-MB-231 cell mi-
gration up to 1.50 ± 0.16-fold but had no effect on the
migratory ability of MCF-7 cells compared with that of
untreated cells (Fig. 4b, untreated vs. VEGF-A, p =
0.003). In addition, we investigated whether VEGF-A
played a role as a migration-activating mediator in
HCC-38 cells. As expected, VEGF-A treatment signifi-
cantly increased HCC-38 cell migration up to 1.56 ±
0.26-fold (Additional file 7: Figure S7B, untreated vs.
VEGF-A, p < 0.001).
To verify the exogenous VEGF-A-mediated intracellu-
lar signaling pathways responsible for the increased mi-
gratory ability of MDA-MB-231 cells, the levels of FAK,
AKT, and ERK phosphorylation were evaluated. After
cell starvation for 4 h, treatment with exogenous VEGF-
A for 15 min, 30 min, 60 min, and 48 h induced the
periodic fluctuation of the phosphorylation levels of FAK
and AKT and generally increased phosphorylated FAK
and AKT, but did not affect the phosphorylation level of
Fig. 4 Migration and signaling pathways in VEGF-A-stimulated MDA-MB-231 cells. a Images of the crystal violet-stained cells that migrated horizontally
in the trans-well migration assay. b The absorbance values of extracted crystal violet in migrated cells. Migration of the VEGF-A-treated MDA-MB-231
cells (~1.5-fold) was enhanced compared with that of the untreated control cells. c Representative image of western blotting of phosphorylated AKT,
FAK and ERK and total AKT, FAK and ERK in MDA-MB-231 cells treated with VEGF-A. The levels of FAK and AKT phosphorylation were increased in the
VEGF-A-treated MDA-MB-231 cells, but the level of ERK phosphorylation was similar between VEGF-A-treated MDA-MB-231 cells and the untreated
cells. d Densitometric quantifications of phosphorylation levels of FAK, AKT, and ERK in the VEGF-A-treated cells relative to the untreated cells. β−actin
was used as an internal reference. All experiments were performed at least in triplicate, and the values are the mean values ± standard deviation.
*p < 0.05, **p < 0.001
Choi et al. BMC Cancer  (2016) 16:570 Page 10 of 14
ERK in MDA-MB-231 cells (Fig. 4c, d). These data indi-
cated that the activation of the FAK and PI3K/AKT sig-
naling pathways mediated by the exogenous VEGF-A
increased the migratory ability of MDA-MB-231 cells.
Similar results that VEGF-A stimulated FAK, AKT, and
ERK were also observed in HCC-38 cells (Additional file 7:
Figure S7C, D).
Discussion
The role of miR-200 family in regulating the migration
and invasion of different cancer cell types is controver-
sial [10, 11]. Moreover, only a small number of miR-200
target genes that regulate cell migration and cancer me-
tastasis has been identified [4, 6], and the mechanisms
underlying the functions of miR-200b/200a/429 cluster
and miR-141/200c cluster in TNBC cells are not fully
understood. It is well-known that the miR-200 family ex-
pression levels are significantly lower in highly migratory
TNBC cells and metastatic TNBC tumors than other
types of breast cancer cells and tumors. In addition,
Vrba L et al. reported the repression of miR-200 and
miR-141 expression due to aberrant epigenetic gene si-
lencing in aggressive cancer cells, including MDA-MB-
231 cells, indicating that the downregulation of miR-200
may contribute to an aggressive TNBC phenotype [17].
ZEB1 and SIP1 have been found to repress primary tran-
script and mature miR-200 expression in mesenchymal
types of breast cancer cells, suggesting a downregulation
of miR-200 in TNBC cells through a potential double-
negative feedback loop between ZEB1/SIP1 and the
miR-200 family [18]. Manav K et al. reported the highest
expression of miR-200s in the highly metastatic 4T1
cells, a mouse TNBC cell line, which was consistent with
acquisition of epithelial traits in 4T1 cells compared with
the weakly metastatic 4TO7 cells. In addition, 4T1
tumors exhibit spontaneous metastasis and colonization
of distant organs, which is enhanced by miR-200 overex-
pression in experimental animal models, furthermore,
higher expression of miR-200 levels were found in lung-
pleural metastasis samples relative to primary tumor
samples in breast cancer patients. These data support
the potential role of miR-200s in migration, invasion,
metastatic colonization, and metastatic dissemination
[6]. Recently, Avery-Kiejda KA et al. found that the miR-
200 cluster is upregulated in invasive ductal carcinomas
with both lymph node-positive and lymph node-negative
TNBC compared with matched normal adjacent tissues
[19]. Their reports of in vivo experimental and clinical
evidence may indicate that tumor cell populations with
increased aggressiveness may have higher miR-200 clus-
ter levels than their less aggressive counterparts within
the same TNBC and in normal tissues, the miR-200
cluster, though being generally reduced in TNBC com-
pared with other subtypes, is upregulated in TNBC cells
that may support metastatic dissemination. We showed
here that the overexpression of miR-200b/200a/429 clus-
ter or miR-141/200c cluster strongly promoted the mi-
gration and invasion of MDA-MB-231, HCC-38, and
Hs578T cells, typical claudin-low and mesenchymal sub-
types of TNBC cell lines [20], compared with those of
an ER-positive breast cancer cell line, MCF-7 cells. The
migratory and invasive ability of MDA-MB-231 cells was
substantially more enhanced in those that overexpressed
the miR-141/200c cluster than in those with the miR-
200b/200a/429 cluster. These data suggest that the dif-
ferent roles of the miR-200 family members, such as
miR-200a, miR-200b, miR-200c, miR-141, and miR-429,
on the migration and invasion of different subtypes of
human breast cancer cell lines classified by molecular
characterization should be further investigated [21].
Dysregulation of the PI3K/AKT signaling pathway has
been implicated in mammary carcinogenesis and was
suggested to be the mechanism underlying the survival
of invasive breast cancer cells [22]. Furthermore, an acti-
vated AKT signaling pathway, a common dysregulation
observed in breast cancers, has been shown to promote
cancer cell growth, survival, and metastasis [23]. FAK is
a cytoplasmic tyrosine kinase that plays crucial roles in
integrin-mediated signal transduction, and FAK localizes
to the sites where transmembrane integrin receptors
are clustered to mediate various intracellular signal-
transduction pathways [5, 24]. Many recent studies have
reported that an increased level of FAK expression highly
correlates with the invasiveness and metastasis of human
tumors [25–27]. We found that the phosphorylation levels
of AKT and FAK in MDA-MB-231 cells were elevated by
stable overexpression of the miR-200b/200a/429 cluster
and the miR-141/200c cluster. Additionally, increased
integrin-αV and phosphorylated FAK co-localized in the
transmembrane of miR-200b/200a/429 cluster- and miR-
141/200c cluster-transduced MDA-MB-231 cells. These
data suggest that the stable overexpression of the 200b/
200a/429 cluster and the miR-141/200c cluster in MDA-
MB-231 cells may affect the secretion of cytokines or
growth factors to activate FAK or the PI3K/AKT signaling
pathway. The regulation between the miR-200 family and
FAK is not fully understood. A model indicating that a
stiffer matrix of breast cancers will activate FAK, which in-
hibits the miR-200 family and allow for a mesenchymal
phenotype has been proposed [28]. This model is not con-
sistent with our observation that the overexpression of the
miR-141/200c cluster or the miR-200b/200a/429 cluster
increased clustering and expression of integrins and acti-
vated FAK and AKT, which regulate cell migration. Our
finding proposes a positive cross-talk between FAK and
overexpressed miR-200 in TNBC cells.
Many studies have been aimed at understanding the
role of cytokines and growth factors in breast cancer
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progression. Some cytokines and growth factors (IL-1,
IL-6, IL-11, TGF-β, and VEGF) stimulate the prolifera-
tion and invasion of breast cancer cells, whereas others
(IL-12, IL-18, and IFN) suppress breast cancer progres-
sion [29]. A recent study reported that miR-200 inhibits
angiogenesis by targeting IL-8 and CXCL1 secreted by
tumor endothelial and cancer cells [30]. Our study dem-
onstrated that the overexpression of the miR-200b/200a/
429 cluster or the miR-141/200c cluster in MDA-MB-
231 cells led to a decrease in the secretion of IL-2, IL-4,
IL-5, IL-10, IL-13, GM-CSF, INF-γ and TNF-α but a sig-
nificant increase in the secretion of VEGF-A. VEGF has
been reported to activate the PI3K/AKT/forkhead signal-
ing pathway to promote angiogenesis in human endo-
thelial cells [31]. In addition, VEGF-A, the most potent
angiogenic factor in tumor angiogenesis, induces oligo-
dendrocyte precursor cell migration through a ROS- and
FAK-dependent mechanism [32]. VEGF-A is known to
be a direct target of miR-200b [33], but in our results, a
significant decrease in VEGF-A levels assessed by west-
ern blotting was not observed in miR-200b/200a/429-
and miR-141/200c-transduced MDA-MB-231 cells or in
miR-141/200c-transduced HCC-38 cells relative to con-
trol. Moreover, VEGF-A secretions in MDA-MB-231,
HCC-38, and Hs578T cells were increased by the over-
expression of the miR-141/200c cluster. The compre-
hensive interactions between miRNAs and transcription
factors (TFs) are expected to comprise “wired” genetic
networks to regulate the expression of target genes [34].
In examples of an incoherent feed-forward loop, the dir-
ect regulatory effect of TFs on the target gene (VEGF-A)
is opposed to the indirect regulatory effect through miR-
200 regulation. Taking the comprehensive interactions
between miRNAs and protein-coding genes, we propose
that miR-200 overexpression in TNBC cells can affect
TFs (HIF-1, CREB) or signals (PI3K/AKT) to regulate
VEGF-A secretion through an incoherent feed-forward
loop. An autocrine loop for VEGF-A to induce breast
cancer cell migration/invasion has been well docu-
mented [35, 36]. From these reports, we assume that the
VEGF-A secreted by miR-200 overexpression interacts
with its receptors, such as neuropilin-1 (NP-1) and
VEGFR, and stimulates the PI3K/AKT signaling path-
way, thus promoting TNBC cell migration and invasion.
In this study, we demonstrated that treatment with
VEGF-A led to an increase in migratory ability and acti-
vated FAK and the PI3K/AKT signaling pathway in
MDA-MB-231 cells and HCC-38 cells. Our results
strongly support that VEGF-A-mediated FAK or PI3K/
AKT signaling pathway modulates cancer cell migration
and invasion. By down-regulating miR-200b expression
through the PI3K/AKT signaling pathway, the chemokine
CCL5 (formerly RANTES) promotes VEGF-dependent
angiogenesis in human chondrosarcomas [15]. In addition,
synthetic miR-200c downregulates VEGF-A by the direct
targeting of the 3’UTR of VEGF-A mRNA in a lung can-
cer cell line [16]. Contrary to above studies, in this study,
the stable overexpression of the miR-200b/200a/429 clus-
ter and the miR-141/200c cluster in MDA-MB-231 cells
resulted in increased VEGF-A secretion and induced AKT
and FAK phosphorylation. Blocking the PI3K/AKT or
FAK signaling pathways using chemical inhibitors in-
hibited the enhanced migration and invasion in MDA-
MB-231 cells overexpressing the miR-200b/200a/429
cluster or the miR-141/200c cluster. Inhibiting the
VEGF-A-mediated pathway using anti-VEGF-A-neu-
tralizing antibodies suppressed the elevated AKT and
FAK phosphorylation in MDA-MB-231 cells overex-
pressing miR-141/200c cluster, reversing the enhanced
migratory and invasive abilities. These results suggest
that the activation of FAK and the PI3K/AKT sig-
naling pathway are directly mediated by elevated
VEGF-A secretion, which is involved in the increased
migratory and invasive abilities of miR-141/200c cluster-
transduced MDA-MB-231 cells. On the other hand, FAK-
and PI3K/AKT-independent signaling pathways activated
by VEGF-A may lead to an enhanced migratory ability in
miR-200b/200a/429 cluster-transduced MDA-MB-231
cells. The present study implies that aberrant expres-
sion of miR-200b/200a/429 cluster or the miR-141/
200c cluster may play a pro-metastasis role leading to
the promotion of migration and invasion of MDA-
MB-231 cells.
Conclusions
The stable overexpression of the miR-141/200c cluster
promoted the migratory and invasive ability of TNBC
cells through the strong activation of FAK and the PI3K/
AKT signaling pathway by increasing VEGF-A secretion
compared with the miR-200b/200a/429 cluster.
Additional files
Additional file 1: Figure S1. Comparison of gene expression and
migration in miR-200b/200a/429 or miR-141/200c-transduced MCF-7 and
MDA-MB-231 cells. (A) Fluorescence images of green fluorescent protein
in MCF-7 and MDA-MB-231 cells that were transduced using lentivirus
encoding both GFP and miR-200 family members. Strong GFP expression
was detected in the miR-200 family-transduced cells. Scale bar, 50 μm (B)
RT-PCR analysis of genes related to epithelial-mesenchymal transition
(E-cadherin, fibronectin, vimentin, ZEB1, ZEB2, and snail). E-cadherin
expression was induced in the miR-200 family-transduced MDA-MB-231
cells. While snail expression was increased, ZEB1 expression was lower in
the miR-200 family-transduced MDA-MB-231 cells than in the non-
transduced control cells. (C) Images of the crystal violet-stained cells that
migrated horizontally in the trans-well migration assay. The stable
transduction of miR-200 family slightly suppressed the migratory ability of
MCF-7 cells but significantly enhanced the migratory ability of MDA-MB-
231 cells. (D) Images of the laterally migrated cells as determined using a
wound-healing assay. Enhanced lateral migration ability was observed in
only the miR-200 family-transduced MDA-MB-231 cells. (E) Quantitative
analysis of the migratory ability of MCF-7 and MDA-MB-231 cells assessed
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using trans-well migration assay. The stable transduction of miR-200ab
and miR-200c significantly increased the migratory ability of MDA-MB-231
cells but did not influence on the migratory ability of MCF-7 cells. (F)
Quantitative analysis of the migratory ability of MCF-7 and MDA-MB-231
cells assessed using wound-healing assays. The stable transduction of
miR-200ab led to a significant increase in lateral migration of MDA-MB-
231 cells. All experiments were performed at least in triplicate, and the
values are the mean values ± standard deviation. *p < 0.05. (JPG 292 kb)
Additional file 2: Figure S2. Flow cytometric analysis of GFP in miR-
200b/200a/429 or miR-141/200c-transduced MCF-7 and MDA-MB-231
cells. Flow cytometry analysis of the percentage of GFP-positive cells
among the miR-200ab- and miR-200c-transduced MCF-7 and MDA-MB-
231 cells. GFP-positive cells among the miR-200 family-transduced MCF-7
and MDA-MB-231 cells were found to be greater than 90 %. (JPG 118 kb)
Additional file 3: Figure S3. Migration in miR-141/200c-transduced
MDA-MB-231 cells. Quantitative analysis of the migratory ability in of
MDA-MB-231 and miR-141/200c-transduced MDA-MB-231 cells was
performed in trans-well migration assay with 10 % FBS in the lower
chamber. The migratory ability of the miR-200c cells (~1.5-fold) was
significantly increased compared with those of the control cells. All
experiments were performed at least in triplicate, and the values are the
mean values ± standard deviation. **p < 0.001. (JPG 14 kb)
Additional file 4: Figure S4. Migration in miR-141/200c-transduced
HCC-38 and Hs578T cells treated with an anti-VEGF-A-neutralizing
antibody. (A, D) Migration in miR-141/200c-transduced HCC-38 and
Hs578T cells. Images of the crystal violet-stained cells that migrated
horizontally in the trans-well migration assay (upper). The absorbance
values of extracted crystal violet in migrated cells (lower). The migratory
abilities of the miR-200c cells (~1.6-fold and ~1.7-fold, HCC-38 and
Hs578T, respectively) were significantly increased compared with those of
the control cells. (B, E) Measurement of the secreted levels of cytokines
and growth factors (IL-2, IL-4, IL-5, IL-10, IL-12, IL-13, GM-CSF, IFN-γ, TNF-α,
and VEGF-A). Transduction of miR-141/200c into HCC-38 and Hs578T cells
promoted significantly higher VEGF-A secretion than that of control cells.
(C, F) Trans-well migration of anti-VEGF-A-neutralizing antibody-treated
cells. The enhanced migration of the miR-141/200c-transduced HCC-38
cells were significantly suppressed by treatment with anti-VEGF-
A-neutralizing antibodies, but miR-141/200c-transduced Hs578T cells still
showed increased migratory ability compared with control cells. *p < 0.05,
**p < 0.001. (JPG 188 kb)
Additional file 5: Figure S5. microRNA expression levels of miR-200
cluster transduced MCF-7, MDA-MB-231, HCC-38, and Hs578T cells.
Quantitative real-time RT-PCR of microRNAs (miR-200a, miR-200b, and
miR-200c). (A, B, C) microRNAs in MCF-7 cells. The miR-200ab cells
transduced with the miR-200b/200a/429 cluster exhibited high levels of
expression of miR-200a (~60-fold) and miR-200b (~40-fold) relative to
those of the control cells. The miR-200c cells transduced with the miR-
200c/141 cluster exhibited remarkably high levels of expression of miR-
200c (~266-fold) relative to those of the control cells. (D, E, F) microRNAs
in MDA-MB-231. The miR-200ab cells transduced with the miR-200b/
200a/429 cluster exhibited high expression levels of miR-200a (~6-fold)
and miR-200b (~40-fold) relative to those of the control cells. The miR-
200c cells transduced with the miR-200c/141 cluster exhibited remarkably
high expression levels of miR-200c (~93-fold) relative to those of the
control cells. (G) microRNAs in HCC-38. The miR-200c cells transduced
with the miR-200c/141 cluster exhibited remarkably high expression
levels of miR-200c (~252-fold) relative to those of the control cells. (H)
microRNAs in Hs578T. The miR-200c cells transduced with the miR-200c/
141 cluster exhibited remarkably high expression levels of miR-200c
(~205-fold) relative to those of the control cells. *p < 0.05, **p < 0.001.
(JPG 50 kb)
Additional file 6: Figure S6. VEGF-A expression and signaling
pathways associated with enhanced migration in miR-141/200c-trans-
duced HCC-38 cells. (A) Representative image of western blotting analysis
of VEGF-A levels. β− actin was used as an internal reference. (B) Densitometric
quantification of VEGF-A in the miR-141/200c-transduced cells relative to the
control cells. (C) Western blotting analysis of the levels of phosphorylated FAK,
AKT, ERK, and integrin-αV expression. The levels of FAK and AKT
phosphorylation were significantly higher in the miR-141/200c-transduced
cells than in the control cells, but the level of ERK phosphorylation was
similar between the miR-141/200c-transduced cells and control cells. The
miR-141/200c-transduction also increased the level of integrin-αV expression.
β− actin was used as an internal reference. (D) Densitometric quantification
of FAK, AKT, and ERK phosphorylation in the miR-141/200c-transduced cells
relative to the control cells. (E) Immunofluorescence analysis of
phosphorylated FAK and integrin-αV. Phosphorylated FAK and integrin-αV
were overexpressed and highly localized at membrane surfaces in the miR-
141/200c-transduced cells. *p< 0.05. Scale bar, 10 μm. (JPG 102 kb)
Additional file 7: Figure S7. Migration and signaling pathways in VEGF-
A-stimulated HCC-38 cells. (A) Migration in VEGF-A-stimulated HCC-38 cells.
Images of the crystal violet-stained cells that migrated horizontally in the
trans-well migration assay. (B) The absorbance values of extracted crystal
violet in migrated cells (lower). Migration of the VEGF-A-treated HCC-38 cells
(~1.6-fold) was enhanced compared with that of the untreated control cells.
(C) Representative image of western blotting of phosphorylated AKT, FAK
and ERK and total AKT, FAK and ERK in HCC-38 cells treated with VEGF-A.
(D) Densitometric quantification of VEGF-A in the miR-141/200c-transduced
cells relative to the control cells. β − actin was used as an internal reference.
The levels of FAK, AKT, and ERK phosphorylation were increased in the
VEGF-A-treated HCC-38 cells. *p < 0.05, **p < 0.001. (JPG 108 kb)
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